[Pseudo aldosteronism].
Miyamori
Isamu
I
Third Department of Medicine, University of Fukui Faculty of Medical Sciences.
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000037:antagonists & inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D006035:Glycyrrhiza / Q000009:adverse effects; D019695:Glycyrrhizic Acid / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006929:Hyperaldosteronism / Q000209:etiology* / Q000628:therapy; D006973:Hypertension / Q000150:complications; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000451:Mineralocorticoid Receptor Antagonists; D019695:Glycyrrhizic Acid; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2; D006854:Hydrocortisone